Carafate Oral Suspension 01
Carafate Suspension
Product Images NDC 58914-170
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carafate (NDC 58914-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carafate Oral Suspension 02
Carafate Oral Suspension 03
Carafate is a medication in oral suspension form containing 1g/10mL of sucralfate. It is recommended to shake well before use and avoid freezing. The medication should be stored in a controlled room temperature environment between 0-25°C (6877 F) according to USP guidelines. The listed company for this product is Allergan, and the text also mentions that Carafate is a registered trademark of Aptais: [harms Canada ULC, also an Allergan office.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
